Richard Peters - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Richard Peters since 7/7/2023

Holdings reported by Richard Peters for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2,074 $15.1 K $7.29 Jun 20, 2024 Direct
Stock Options (Right to Buy) 4,185 Jun 20, 2024 Direct Common Stock

Transactions reported by Richard Peters for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership